occurs when inflammatory disease activity at the eyelid margins traumatizes the ocular surface, aggravating keratitis and conjunctivitis.
The common presentation for demodicosis includes ocular irritation, blepharoconjunctivitis
, cylindrical dandruff, and symptoms refractory to usual medical therapies in an immunocompetent person aged greater than 50.
Most of the animals have appeared ill, and the illness was said to start as a blepharoconjunctivitis
Based on our clinical experience with AzaSite Plus and DexaSite, including a completed Phase 3 study in blepharoconjunctivitis
, we believe that the design of the DOUBle Phase 3 program provides us with a unique opportunity to advance two promising products for the treatment of this disease in a single study.
Many of these conditions, such as complex cases of blepharitis, blepharoconjunctivitis
, limbal and peripheral corneal infiltrates, non-perforating abrasions, and foreign bodies, can present to and be managed by an optometrist, especially those with additional supply (AS) therapeutic qualifications.
Herpes simplex blepharoconjunctivitis
presenting as complete acquired ankyloblepharon.
InSite Vision Incorporated (OTCBB: INSV) today announced that abstracts detailing the clinical response of blepharoconjunctivitis
patients treated with dexamethasone formulated in DuraSite[R] and the safety of bromfenac formulated in DuraSite on ocular tissues have been accepted for presentation at the 2011 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-5, 2011 in Fort Lauderdale, Florida.
An infectious blepharitis, if not managed properly, can easily lead to development of blepharoconjunctivitis
whereby the bacteria infect the mucous membranes of the conjunctiva as well as the eyelid margins, and can also be associated with a marginal keratitis (see next article in this series).
At the recent BIO CEO Investor conference in New York City, InSite Vision shared additional data from the 2008 Phase 3 trial of AzaSite Plus in blepharoconjunctivitis
The company completed its first Phase 3 clinical trial of ISV-502 (AzaSite Plus[TM]), a topical combination antibiotic/corticosteroid product for the treatment of blepharoconjunctivitis
, or lid margin disease.